Jenna Grabey
BA (Hons), MSc
Clinical Data Manager
I started work at the Nuffield Department of Primary Care Health Sciences in January 2018. I am the Clinical Data Manager for the INVICTUS trial, which aims to see if a novel vaccine, used in conjunction with the standard flu vaccine, offers increased protection to older adults from influenza-like illness. As well as this I work on the ARCHIE trial, also an influenza trial that investigates the early use of antibiotics in children with influenza, and the MaSC trial.
Prior to this I worked at the Medical Research Council at UCL as a Clinical Data Manager. The main trial I worked on there was CAP-IT, a trial investigating duration and dose of the antibiotic amoxicillin to treat paediatric pneumonia as well as antimicrobial resistance. I also worked on a two oncology trials in my role at the MRC CTU at UCL.
Recent publications
-
Automated virtual reality (VR) therapy (gameChange) treating agoraphobic avoidance and distress in patients with psychosis: a multicentre, parallel group, single-blind, randomised controlled trial in England with mediation and moderation analyses
Journal article
FREEMAN D. and FREEMAN D., (2022), Lancet Psychiatry
-
Colchicine for COVID-19 in adults in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial
Journal article
PRINCIPLE Trial Collaborative Group None. et al, (2021)
-
Platform Randomised trial of INterventions against COVID-19 in older peoPLE (PRINCIPLE): Protocol for a randomised, controlled, open-label, adaptive platform, trial of community treatment of COVID-19 syndromic illness in people at higher risk
Journal article
Hayward G. et al, (2021), BMJ Open, 11
-
Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trial
Journal article
PRINCIPLE Collaborative Group None. et al, (2021)
-
Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
Journal article
Butler CC. et al, (2021), The Lancet, 397, 1063 - 1074